Streetbeat News

Products Services

SHPH

Shuttle Pharmaceuticals shares rose following the issuance of a new U.S. patent for their selective histone deacetylase inhibitors, which are used in treating human diseases.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 1:07 pm

CYTH

Cyclo Therapeutics presented preliminary data from its Phase 3 study of Trappsol Cyclo for Niemann-Pick Disease Type C1 at the SSIEM Symposium. Topline data from the study is expected in the first half of 2025.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 1:06 pm

ROKU

The NFL Zone returns to the Roku platform for the 2024-25 season, offering fans access to NFL games, highlights, and more. The platform allows easy subscription to NFL+ using Roku Pay.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 1:05 pm

SHPH

Shuttle Pharma has been granted a U.S. patent for its selective histone deacetylase inhibitors, which are used in the treatment of human diseases. This development could enhance the company's intellectual property portfolio and potentially lead to new therapeutic applications.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 1:05 pm

OPTN

Optinose has published peer-reviewed results from the ReOpen1 and ReOpen2 trials, demonstrating the efficacy of EDS-FLU in treating chronic rhinosinusitis, with or without prior sinus surgery.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 1:05 pm

TSLA

Tesla's announcement of a timeline for releasing its full self-driving (FSD) technology in China and Europe by Q1 2025 has been criticized by GLJ Research CEO Gordon Johnson as a 'meaningless announcement' aimed at boosting stock prices. Johnson accuses Tesla of using such announcements to counteract poor earnings results. Despite this, Tesla bull Gary Black believes the timeline aligns with expectations. Tesla's stock has declined 11.7% year-to-date amid challenges like waning demand and increased competition.

Portfolio Pulse from Anan Ashraf

September 05, 2024 | 1:04 pm

SCLX

Scilex Holding Company will present research on dosing adjustments for gout patients with renal impairment using their product GLOPERBA® at the 2024 American College of Rheumatology Convergence conference. The presentation highlights the unique precision dosing capabilities of GLOPERBA®, which recently received FDA approval for an updated label.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 1:02 pm

CPCAY

EADSY

RLLCF

Cathay Pacific's A350 fleet faced an engine issue, prompting Airbus and Rolls-Royce to address the situation. While no global inspections are currently advised, the final decision lies with regulators. Airlines like Singapore Airlines and Japan Airlines are conducting precautionary checks. The incident involved a fuel leak in a Rolls-Royce engine, and Cathay Pacific plans to resume operations after repairs.

Portfolio Pulse from Nabaparna Bhattacharya

September 05, 2024 | 1:02 pm

LRN

Stride, Inc. has launched Road2Teach, a new teacher preparation program in Indiana, approved as a Transition to Teaching education preparation program. It combines online coursework and a teaching internship to help aspiring teachers transition and pass certification exams.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 1:00 pm

USO

OPEC+ is reportedly close to agreeing on delaying an increase in oil output, which could impact oil prices. This decision is significant for investors in oil-related assets, including the United States Oil Fund (USO).

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:51 pm